Analystreport

Alder BioPharmaceuticals (NASDAQ: ALDR) was given a new $20.00 price target on by analysts at Canaccord Genuity. They now have a "buy" rating on the stock.

ALDER BIOPHARMACEUTICALS INC  (ALDR) 
Last alder biopharmaceuticals inc earnings: 8/6 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alderbio.com/node/5806